| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 05/29/2001 | US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents |
| 05/29/2001 | US6239172 Mixture of angiogenic growth factor and l-arginine; brain and cardiovascular disorders |
| 05/29/2001 | US6239171 Tocotrienols and tocotrienol-like compounds and methods for their use |
| 05/29/2001 | US6239170 Applying 5-lipoxygenase inhibitor |
| 05/29/2001 | US6239169 Non-steroidal polycyclic ring sulphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors |
| 05/29/2001 | US6239167 Antitumor compositions containing taxane derivatives |
| 05/29/2001 | US6239165 Liquid pharmaceutical formulation containing zotepine |
| 05/29/2001 | US6239164 Immunophilin affinity; nonimmunosuppressant |
| 05/29/2001 | US6239162 Method for treating depression |
| 05/29/2001 | US6239161 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 05/29/2001 | US6239160 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyrimidines, processes for their preparation, compositions comprising them, and their use as pesticides |
| 05/29/2001 | US6239157 Inhibition of osteoclastogenesis |
| 05/29/2001 | US6239156 Reduction of glutamate neurotoxicity by the administration of the neuroprotectant riluzole, |
| 05/29/2001 | US6239155 Phenyl-substituted 1,4-dihydropyridines |
| 05/29/2001 | US6239154 Arylacetamides, agonists at kappa opioid receptors. |
| 05/29/2001 | US6239153 Insulin sensitivity enhancer with squaline synthesis inhibitor, which shows a potent depressive effect on diabetic hyperglycemia, |
| 05/29/2001 | US6239152 Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| 05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
| 05/29/2001 | US6239148 Treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a role by eliciting neurogenic pain, insulin resistance in diabetes mellitus or aging, inhibit insulin antagonizing peptide, |
| 05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
| 05/29/2001 | US6239146 Neurotrophic difluoroamide agents |
| 05/29/2001 | US6239144 Administering a tachykinin receptor antagonist, 2-(n-(2-((4-cycdohexyl)piperazin-1-yl)acetyl)amino)-3-(1h-indo l-3-yl)-1-(n-(2-methoxybenzyl)acetylamino)propane, |
| 05/29/2001 | US6239142 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5carboxamides as antiviral agents |
| 05/29/2001 | US6239141 Antibiotic |
| 05/29/2001 | US6239139 13,13A-Didehydroberbine derivatives |
| 05/29/2001 | US6239138 Vitronectin receptor antagonist |
| 05/29/2001 | US6239137 Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity |
| 05/29/2001 | US6239136 Regulating apoptosis in human cells having autoimmune disease |
| 05/29/2001 | US6239135 Arylpiperazines having activity at the serotonin 1A receptor |
| 05/29/2001 | US6239132 Thrombin inhibitors |
| 05/29/2001 | US6239130 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 05/29/2001 | US6239129 Characterised by an indole ring on the aromatic moiety by a cyano group and on the indole nitrogen by an aminoalkyl chain. great affinity for 5-ht2c receptors, useful for depression, panic attacks, obsessive-compulsive disorders, phobias, |
| 05/29/2001 | US6239128 Combating diseases and disorders associated with or mediated by the release of excitatory amino acids, associated with reduced blood flow to the brain and other cns tissue, |
| 05/29/2001 | US6239125 Antiviral agents against herpes viruses. |
| 05/29/2001 | US6239124 Pharmaceutical compositions for the treatment of transplant rejection or autoimmune or inflammatory conditions comprising cyclosporin A and 40-0-(2-hydroxyethyl)-rapamycin |
| 05/29/2001 | US6239123 Use of estrogenic compounds as anti-fungal agents |
| 05/29/2001 | US6239122 Estrone or derivatives of estrone, equilin, or equilenin, antiemetic or for the treatment of other disorders that can be ameliorated by noncompetitive antagonism of the 5-hydroxytryptamine type 3 receptor. |
| 05/29/2001 | US6239121 4- Halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same |
| 05/29/2001 | US6239120 Glucocorticoid having a first pass metabolism in the liver of at least 90% in contact with the intestinal wall area. |
| 05/29/2001 | US6239119 Topical administration of amifostine and related compounds |
| 05/29/2001 | US6239118 Method for preventing restenosis using a substituted adenine derivative |
| 05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
| 05/29/2001 | US6239114 Triterpene derivatives, antitumor |
| 05/29/2001 | US6239113 Topical treatment or prevention of ocular infections |
| 05/29/2001 | US6239112 Water miscible macrolide solutions |
| 05/29/2001 | US6239111 Drug for treating brain diseases, enables prevention or treatment of dementia and similar diseases caused by degeneration or sloughing of neurons, an ally sulfide, sulfoxide or sulfone |
| 05/29/2001 | US6239102 Concentrate comprising, as active agent, (3'-desoxy-3-oxo-mebmc)1-(val)2-cyclosporin, stabilizer selected from oleic acid or palmitoyl oleoyl phosphatidyl glycerol or salts thereof, ethanol |
| 05/29/2001 | US6238914 Nucleic acid |
| 05/29/2001 | US6238883 Neurotransmitter transporter SC6 |
| 05/29/2001 | US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines |
| 05/29/2001 | US6238859 Virus protein antigens of the JC virus |
| 05/29/2001 | US6238703 Core with overcoatings |
| 05/29/2001 | US6238702 High load formulations and methods for providing prolonged local anesthesia |
| 05/29/2001 | US6238697 Methods and formulations for making bupropion hydrochloride tablets using direct compression |
| 05/29/2001 | US6238695 Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 05/29/2001 | US6238693 Multilayer; backings, matrix and protective coatings |
| 05/29/2001 | US6238689 Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 05/29/2001 | US6238683 Drug delivery |
| 05/29/2001 | US6238671 Process for the gentle recovery of extract fractions from hypericum, pharmaceutical preparations containing the same and their use |
| 05/29/2001 | US6238666 Polypeptide |
| 05/29/2001 | US6238665 Anti-edema agent |
| 05/29/2001 | US6238663 Irradiating with light |
| 05/29/2001 | US6238660 Interleukin-12 inducer and medical composition |
| 05/29/2001 | US6238659 Administering a compound influencing the cellular redox state which is a pyrrolidine dithiocarbamate or a derivative and a cytokine |
| 05/29/2001 | US6238654 Cosmetic compositions comprising a film-forming polymer |
| 05/29/2001 | US6238650 Said sunscreen active ingredient is in the form of sol-gel microcapsules containing at least one sunscreen compound. |
| 05/29/2001 | US6238649 Cosmetic and pharmaceutical preparations containing photostable UV filters |
| 05/29/2001 | US6238647 Anticholinergic medicament which is selected from the group consisting of ipratropium, atropine, oxitropium and salts thereof |
| 05/29/2001 | US6238397 Spine distraction implant and method |
| 05/29/2001 | US6238284 Transdermal compositions with enhanced skin penetration properties |
| 05/29/2001 | CA2325778A1 Use of 1,1-dioxoperhydro-1,2,4-thiadiazines |
| 05/29/2001 | CA2317155A1 Method of treating the syndrome of coronary heart disease risk factors in humans |
| 05/29/2001 | CA2195923C Azetidines |
| 05/29/2001 | CA2127530C Metal complexes of water soluble texaphyrins |
| 05/29/2001 | CA2091506C Thieno[3,2-b]pyridine derivatives |
| 05/29/2001 | CA2053339C Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines |
| 05/29/2001 | CA2019273C Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
| 05/26/2001 | CA2291346A1 Antifungal solutions |
| 05/25/2001 | WO2001036977A2 Identification of disease markers involving mass-based-separation |
| 05/25/2001 | WO2001036973A2 Method for solubilising optical markers |
| 05/25/2001 | WO2001036686A2 Genomic polymorphism for predicting therapeutic response |
| 05/25/2001 | WO2001036684A2 Mammalian toxicological response markers |
| 05/25/2001 | WO2001036677A1 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/25/2001 | WO2001036656A2 A complex between hyaluronic acid and a biomolecule and its use |
| 05/25/2001 | WO2001036646A1 Inhibiting gene expression with dsrna |
| 05/25/2001 | WO2001036626A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | WO2001036624A1 High order nucleic acid based structures |
| 05/25/2001 | WO2001036618A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036599A1 Microparticle-based transfection and activation of dendritic cells |
| 05/25/2001 | WO2001036583A1 Continuous-flow method for preparing microparticles |
| 05/25/2001 | WO2001036510A2 Use of poly(diallylamine) polymers |
| 05/25/2001 | WO2001036476A2 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | WO2001036470A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 05/25/2001 | WO2001036441A1 Antisense modulation of src-3 expression |
| 05/25/2001 | WO2001036440A1 23 human secreted proteins |
| 05/25/2001 | WO2001036438A1 Novel ribose compounds |
| 05/25/2001 | WO2001036437A1 β-D-5-THIOXYLOSE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE |